ACCESSION: MSBNK-SMB_Measured-HSA032P0233002
RECORD_TITLE: Characterized; Aspartyl-Valine; LC-ESI-QTOF; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 14
COMMENT: RAW_SPEC {'HC12-pos_1325': {'bp': 2954.0, 'sum': 9299.0}, 'RA10-pos_1247': {'bp': 1465.0, 'sum': 4959.0}, 'HC1-pos_1283': {'bp': 1298.0, 'sum': 4336.0}, 'HC1-pos_1307': {'bp': 1230.0, 'sum': 4735.0}, 'HC5-pos_1349': {'bp': 835.0, 'sum': 2791.0}, 'RA21-pos_1051': {'bp': 770.0, 'sum': 2801.0}, 'HC3-pos_1429': {'bp': 715.0, 'sum': 2601.0}, 'RA21-pos_1057': {'bp': 646.0, 'sum': 2226.0}, 'RA5-pos_1382': {'bp': 531.0, 'sum': 2119.0}, 'HC16-pos_1446': {'bp': 504.0, 'sum': 1878.0}, 'RA25-pos_1218': {'bp': 418.0, 'sum': 1586.0}, 'HC25-pos_1243': {'bp': 316.0, 'sum': 1382.0}, 'QC3-pos_1248': {'bp': 250.0, 'sum': 1151.0}, 'QC2-pos_1219': {'bp': 239.0, 'sum': 1279.0}}
COMMENT: RETENTION_TIME_STDEV 0.021
COMMENT: PRECURSOR_M/Z_RAW 233.112646
COMMENT: PRECURSOR_M/Z_STDEV 0.000748
COMMENT: PRECURSOR_IN_MS1 mz 233.113190; int 47.256; delta(ppm) 10.741011
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 13.106; C8H17N4O2P; [M+H]+; delta(ppm) -13.106088
COMMENT: PROPOSED_MF SevenGoldenRules 7.341; C7H21O6P; [M+H]+; delta(ppm) -7.341477
COMMENT: PROPOSED_MF SevenGoldenRules 0.228; C9H16N2O5; [M+H]+; delta(ppm) -0.228344
COMMENT: PROPOSED_MF MS-FINDER 4.163; C9H16N2O5; [M+H]+; delta(ppm) -0.227645
COMMENT: PROPOSED_MF MS-FINDER 3.028; C10H12N6O; [M+H]+; delta(ppm) -5.964798
COMMENT: PROPOSED_MF MS-FINDER 2.864; C5H12N8O3; [M+H]+; delta(ppm) 11.291898
COMMENT: PROPOSED_MF MS-FINDER 2.753; C8H17N4O2P; [M+H]+; delta(ppm) -13.050350
COMMENT: PROPOSED_MF MS-FINDER 2.668; C6H20N2O5S; [M+H]+; delta(ppm) -14.688766
COMMENT: PROPOSED_MF MS-FINDER 2.574; C5H20N4O2S2; [M+H]+; delta(ppm) 13.301257
COMMENT: PROPOSED_MF MS-FINDER 2.498; C13H16N2S; [M+H]+; delta(ppm) 10.505922
COMMENT: PROPOSED_MF MS-FINDER 2.156; C10H20N2S2; [M+H]+; delta(ppm) -3.955509
COMMENT: PROPOSED_MF SIRIUS5_Sirius 43.119; C9H16N2O5; [M+H]+; delta(ppm) -0.227645
COMMENT: PROPOSED_MF SIRIUS5_Sirius 27.101; C10H12N6O; [M+H]+; delta(ppm) -5.964798
COMMENT: PROPOSED_MF SIRIUS5_Sirius 15.945; C10H20N2S2; [M+H]+; delta(ppm) -3.955509
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H16N2O5; [M+H]+; delta(ppm) -0.227645
COMMENT: PROPOSED_MF SIRIUS6_Sirius 75.907; C9H16N2O5; [M+H]+; delta(ppm) -0.227645
COMMENT: PROPOSED_MF SIRIUS6_Sirius 58.207; C7H14N5O4; [M+H]+; delta(ppm) 5.532093
COMMENT: PROPOSED_MF SIRIUS6_Sirius 49.276; C8H20N2O2Si2; [M+H]+; delta(ppm) -215259.850408
COMMENT: PROPOSED_MF SIRIUS6_Sirius 48.285; C10H12N6O; [M+H]+; delta(ppm) -5.964798
COMMENT: PROPOSED_MF SIRIUS6_Sirius 42.644; C10H17FN2OS; [M+H]+; delta(ppm) 5.604130
COMMENT: PROPOSED_MF SIRIUS6_Sirius 41.480; C9H14BF2NO3; [M+H]+; delta(ppm) 44875.074610
COMMENT: PROPOSED_MF SIRIUS6_Sirius 40.544; C12H13BFNO2; [M+H]+; delta(ppm) 44880.426152
COMMENT: PROPOSED_MF SIRIUS6_Sirius 33.959; C9H20N2OSSi; [M+H]+; delta(ppm) -215260.453715
COMMENT: PROPOSED_MF SIRIUS6_Sirius 25.724; C10H20N2S2; [M+H]+; delta(ppm) -3.955509
COMMENT: PROPOSED_MF SIRIUS6_Sirius 23.849; C5H12F4N6; [M+H]+; delta(ppm) -0.376895
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H16N2O5; [M+H]+; delta(ppm) -0.227645
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.092; CPMKYMGGYUFOHS-UHFFFAOYNA-N; [M+H]+; CC(C)C(NC(=O)C(N)CC(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.533; FYYSQDHBALBGHX-YFKPBYRVSA-N; [M+H]+; CC(C)(C)OC(=O)N[C@@H](CC(N)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.493; OBTCMSPFOITUIJ-UHFFFAOYNA-N; [M+H]+; CC(C)C(N)C(=O)NC(CC(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.322; ZHHUKOQYRGQWAS-UHFFFAOYSA-N; [M+H]+; COC1=C(C=C(C=C1)C(C)=O)C(=O)C=C(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.290; ZMWQOEWNVDTTKC-UHFFFAOYSA-N; [M+H]+; O=C1OC2(O)C(C=3C=CC=CC3)CCCC2C1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.314; VWXQFHJBQHTHMK-LURJTMIESA-N; [M+H]+; N2-Succinyl-L-ornithine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.157; CPMKYMGGYUFOHS-UHFFFAOYNA-N; [M+H]+; Aspartyl-Valine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.123; ODVCESWVBOFPFP-UCROKIRRSA-N; [M+H]+; (2S,3R)-2-[(3S,6R)-3-amino-6-hydroxy-2-oxopiperidinyl]-3-hydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.034; LARRWQRLUSYTHC-UHFFFAOYNA-N; [M+H]+; Threoninyl-Hydroxyproline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.995; HBWOJLKKRRLNRN-UHFFFAOYNA-N; [M+H]+; Hydroxyprolyl-Threonine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.988; OBTCMSPFOITUIJ-UHFFFAOYNA-N; [M+H]+; Valyl-Aspartate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.952; MKYPKZSGLSOGLL-LURJTMIESA-N; [M+H]+; 4-(Glutamylamino) butanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.762; FYYSQDHBALBGHX-YFKPBYRVSA-N; [M+H]+; N(alpha)-t-butoxycarbonyl-L-asparagine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.697; FFJJSWCEJRPJEI-IOMOGOHMNA-N; [M+H]+; UNPD179539
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.645; FUZOZPRKGAXGOB-UHFFFAOYNA-N; [M+H]+; gamma-Glu-Abu
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.594; BTAPKFMRRPXFOK-UHFFFAOYSA-N; [M+H]+; 4-[(2-hydroxypropyl)carbamoyl]-4-formamidobutanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.514; CQCYYMGLQMYXMR-LURJTMIESA-N; [M+H]+; (2S)-2-(4-aminobutanoylamino)pentanedioic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.340; IEFQLTYCECVOLL-UHFFFAOYSA-N; [M+H]+; 2-amino-5-[(1-carboxy-2-methylselanylethyl)amino]-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.310; IYSPVWBYIMXLBK-UHFFFAOYSA-N; [M+H]+; 2-oxopropanoyl 2,6-diaminohexaneperoxoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.162; FUDYOSHJTIAFOK-ZCFIWIBFSA-N; [M+H]+; (4R)-4-amino-5-(4-aminobutanoyloxy)-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.363; ZZXGPXHOIOCZQR-UHFFFAOYSA-N; [M+H]+; CNP0451300
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VWXQFHJBQHTHMK-LURJTMIESA-N; [M+H]+; N2-Succinyl-L-ornithine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.908; MKYPKZSGLSOGLL-LURJTMIESA-N; [M+H]+; 4-(Glutamylamino) butanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.880; CPMKYMGGYUFOHS-UHFFFAOYNA-N; [M+H]+; Aspartyl-Valine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.873; OBTCMSPFOITUIJ-UHFFFAOYNA-N; [M+H]+; Valyl-Aspartate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.791; FYYSQDHBALBGHX-YFKPBYRVSA-N; [M+H]+; N(alpha)-t-butoxycarbonyl-L-asparagine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.788; CQCYYMGLQMYXMR-LURJTMIESA-N; [M+H]+; (2S)-2-(4-aminobutanoylamino)pentanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.763; IYSPVWBYIMXLBK-UHFFFAOYSA-N; [M+H]+; 2-oxopropanoyl 2,6-diaminohexaneperoxoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.760; BTAPKFMRRPXFOK-UHFFFAOYSA-N; [M+H]+; 4-[(2-hydroxypropyl)carbamoyl]-4-formamidobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.723; FUZOZPRKGAXGOB-UHFFFAOYNA-N; [M+H]+; gamma-Glu-Abu
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.723; FFJJSWCEJRPJEI-IOMOGOHMNA-N; [M+H]+; UNPD179539
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.707; ODVCESWVBOFPFP-UCROKIRRSA-N; [M+H]+; (2S,3R)-2-[(3S,6R)-3-amino-6-hydroxy-2-oxopiperidinyl]-3-hydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.558; FUDYOSHJTIAFOK-ZCFIWIBFSA-N; [M+H]+; (4R)-4-amino-5-(4-aminobutanoyloxy)-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.511; HBWOJLKKRRLNRN-UHFFFAOYNA-N; [M+H]+; Hydroxyprolyl-Threonine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.487; LARRWQRLUSYTHC-UHFFFAOYNA-N; [M+H]+; Threoninyl-Hydroxyproline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.375; IEFQLTYCECVOLL-UHFFFAOYSA-N; [M+H]+; 2-amino-5-[(1-carboxy-2-methylselanylethyl)amino]-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.706; FUZOZPRKGAXGOB-WDSKDSINSA-N; [M+H]+; (2S)-2-amino-5-[[(1S)-1-carboxypropyl]amino]-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.638; MKYPKZSGLSOGLL-LURJTMIESA-N; [M+H]+; (2S)-2-amino-5-(3-carboxypropylamino)-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.602; OBTCMSPFOITUIJ-FSPLSTOPSA-N; [M+H]+; (2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]butanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.127; VWXQFHJBQHTHMK-LURJTMIESA-N; [M+H]+; (2S)-5-amino-2-(3-carboxypropanoylamino)pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.112; FYYSQDHBALBGHX-YFKPBYRVSA-N; [M+H]+; (2S)-4-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.700; KYVLWJXMCBZDRL-BQBZGAKWSA-N; [M+H]+; (2S,6S)-2-acetamido-6-aminoheptanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.224; HWBAHOVOSOAFLE-UHFFFAOYSA-N; [M+H]+; 2-[[2-[(2-methylpropan-2-yl)oxycarbonylamino]acetyl]amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.109; CPMKYMGGYUFOHS-UHFFFAOYSA-N; [M+H]+; 2-[(2-amino-3-carboxypropanoyl)amino]-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.749; HBWOJLKKRRLNRN-UHFFFAOYSA-N; [M+H]+; 3-hydroxy-2-[(4-hydroxypyrrolidine-2-carbonyl)amino]butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.726; LARRWQRLUSYTHC-JWXFUTCRSA-N; [M+H]+; (2S,4R)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]-4-hydroxypyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.509; QJDUESMPRYWWDK-UHFFFAOYSA-N; [M+H]+; ethyl 2-[(2-ethoxy-2-oxoethyl)carbamoylamino]acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -2.649; CPMKYMGGYUFOHS; [M+H]+; aspartylvaline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -102.390; OBTCMSPFOITUIJ; [M+H]+; Valyl-Aspartate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -218.801; PHAXHFPQBNHOBW; [M+H]+; Bagaab
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -238.126; FUZOZPRKGAXGOB; [M+H]+; 2-amino-5-(1-carboxypropylamino)-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -252.280; KYVLWJXMCBZDRL; [M+H]+; N-acetyl-L,L-DAP
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -252.555; AKRSAXOGLJEIEZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -257.956; CQCYYMGLQMYXMR; [M+H]+; ACMC-20mqad
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -267.322; MKYPKZSGLSOGLL; [M+H]+; Glugaba
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -274.888; VWXQFHJBQHTHMK; [M+H]+; N2-succinylornithine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -280.054; HBWOJLKKRRLNRN; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -285.563; FFJJSWCEJRPJEI; [M+H]+; N5-(2-Carboxypropyl)glutamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -305.432; FYYSQDHBALBGHX; [M+H]+; Boc-L-asparagine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -337.436; BTAPKFMRRPXFOK; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -338.643; SWPZYVBHCFOANH; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -351.976; NIJAFEMYFNBSBE; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -361.237; LARRWQRLUSYTHC; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -387.467; ODVCESWVBOFPFP; [M+H]+; (2S,3R)-2-[(3S,6R)-3-amino-6-hydroxy-2-oxopiperidin-1-yl]-3-hydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -498.404; RSRNLJYSWSSQMW; [M+H]+; 2''-Deoxytetrahydrouridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -521.723; WDXJRZMTBRUCNA; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -594.033; NKGCUKKJEZWZGB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.911; CPMKYMGGYUFOHS; [M+H]+; aspartylvaline
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -34.813; CPMKYMGGYUFOHS; [M+H]+; 2-(2-amino-3-carboxypropanamido)-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -111.401; OBTCMSPFOITUIJ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -239.802; PHAXHFPQBNHOBW; [M+H]+; Bagaab
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -301.736; AKRSAXOGLJEIEZ; [M+H]+; (2S)-2-amino-5-(2-amino(114C)butanoyloxy)-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -301.750; CQCYYMGLQMYXMR; [M+H]+; N-(gamma-Aminobutyryl)glutamic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -303.625; FUDYOSHJTIAFOK; [M+H]+; (4S)-4-amino-5-(4-aminobutanoyloxy)-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -305.582; PRWBXAXLDJWGAV; [M+H]+; Pentanoic acid, 4-amino-5-((3-carboxypropyl)amino)-5-oxo-, (S)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -318.727; SWPZYVBHCFOANH; [M+H]+; (2S)-2-amino-5-(2-carboxypropan-2-ylamino)-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -324.785; FYYSQDHBALBGHX; [M+H]+; 2-{[(tert-butoxy)carbonyl]amino}-3-carbamoylpropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -328.281; VWXQFHJBQHTHMK; [M+H]+; N(2)-Succinyl-L-Ornithine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.945; CPMKYMGGYUFOHS; [M+H]+; 2-(2-amino-3-carboxypropanamido)-3-methylbutanoic acid
COMMENT: CONFIDENCE Level 3: Tentative candidate, Aspartyl-Valine, CPMKYMGGYUFOHS-UHFFFAOYSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (8); This structural isomer was suggested from the biological context HMDB HMDB0028766;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C9H16N2O5
CH$EXACT_MASS: 232.105922
CH$SMILES: CC(C)C(C(=O)O)NC(=O)C(CC(=O)O)N
CH$IUPAC: InChI=1S/C9H16N2O5/c1-4(2)7(9(15)16)11-8(14)5(10)3-6(12)13/h4-5,7H,3,10H2,1-2H3,(H,11,14)(H,12,13)(H,15,16)
CH$NAME: Aspartyl-Valine
CH$NAME: Aspartyl-Valine
CH$NAME: 2-[(2-amino-3-carboxypropanoyl)amino]-3-methylbutanoic acid
CH$LINK: INCHIKEY CPMKYMGGYUFOHS-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:4991131
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 µm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 2.035
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 233.113145
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00di-9300000000-abc02567cae9c0437592
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  43.0178274 76.0968 43.018137 15.9236 25.10 0.7900 11 f{C2H3O1}/-0.32ppm,p-C7H14N2O4
  46.0291884 41.0787 46.029491 24.4410 28.28 0.2597 10 f{C1H4N1O1}/9.74ppm,p-C8H13N1O4
  55.0540558 113.4145 55.054314 12.4968 55.03 0.7978 13 f{C4H7}/-3.10ppm,p-C5H10N2O5
  70.0285415 269.5568 70.028691 8.7536 111.09 0.8295 14 f{C3H4N1O1}/-2.84ppm,p-C6H13N1O4
  72.0807067 999.0000 72.080864 5.6187 0.00 0.9516 14 f{C4H10N1}/-0.96ppm,p-C5H7N1O5
  82.0651341 75.1763 82.065332 13.8061 49.95 0.7312 14 f{C5H8N1}/0.10ppm,p-C4H9N1O5
  85.0394436 68.0486 85.039655 13.0763 36.50 0.7445 13 f{C3H5N2O1}/-2.30ppm,p-C6H12O4
  86.0965634 78.6964 86.096779 11.0690 51.85 0.6403 10 f{C5H12N1}/1.60ppm,p-C4H5N1O5
  88.0393449 309.8629 88.039569 5.0318 54.01 1.0000 14 f{C3H6N1O2}/0.45ppm,p-C6H11N1O3
  98.0243657 100.1018 98.024638 14.6800 44.85 0.6988 13 f{C4H4N1O2}/7.25ppm,p-C5H13N1O3
  99.0911849 158.5915 99.091462 13.0890 75.02 0.6319 13 f{C5H11N2}/-4.94ppm,p-C4H6O5
  110.0240440 120.8661 110.024379 10.2977 35.15 0.8128 14 f{C5H4N1O2}/3.54ppm,p-C4H13N1O3
  118.0869493 140.8566 118.087331 14.3369 61.87 0.7533 14 f{C5H12N1O2}/5.88ppm,p-C4H5N1O3
  127.0867157 231.1119 127.087152 6.6333 63.75 0.9295 14 f{C6H11N2O1}/0.99ppm,p-C3H6O4
  142.0868652 114.4532 142.087401 10.6132 44.92 0.7621 14 f{C7H12N1O2}/4.29ppm,p-C2H5N1O3
  152.0713410 170.4191 152.071949 10.9357 78.45 0.8053 14 f{C8H10N1O2}/4.84ppm,p-C1H7N1O3
  187.1064029 38.3046 187.107486 22.5700 13.90 0.8966 11 f{C8H15N2O3}/-7.03ppm,p-C1H2O2
PK$NUM_PEAK: 17
PK$PEAK: m/z int. rel.int.
  43.017827 76.10 76
  46.029188 41.08 41
  55.054056 113.41 113
  70.028542 269.56 269
  72.080707 999.00 999
  82.065134 75.18 75
  85.039444 68.05 68
  86.096563 78.70 78
  88.039345 309.86 309
  98.024366 100.10 100
  99.091185 158.59 158
  110.024044 120.87 120
  118.086949 140.86 140
  127.086716 231.11 231
  142.086865 114.45 114
  152.071341 170.42 170
  187.106403 38.30 38
//
